Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-19-018729

EVP, Chief Financial Officer acquired 3,060 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Burke William P. Mr. EVP, Chief Financial Officer 2019-05-14 Grant or award +3,060 15,061 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Burke William P. Mr. EVP, Chief Financial Officer 2019-05-14 Grant or award · Non-qualified Stock Option (Right to Buy) +10,684 10,684 D: show line 2 in the form
Loading xslF345X03/form4.xml…